Peter D Gorycki - GlaxoSmithKline | 人才画像

基本信息

Career Trajectory

Bio

Peter D Gorycki currently works at the Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline. Peter does research in Drug Metabolism, Analytical Chemistry, Chemical Biology and Organic Chemistry.

Research Interests

Papers共 36 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Cyanide Trapping of Iminium Ion Reactive Metabolites: Implications for Clinical Hepatotoxicity

Xiusheng Miao,Gordon J. Dear,Claire Beaumont,Giovanni Vitulli, Gary Collins,Peter D. Gorycki,Andrew W. Harrell,Melanie Z. Sakatis

Chemical Research in Toxicology（2024）

Cited0Views0WOSBibtex

In Vivo Biodistribution and Pharmacokinetics of Sotrovimab, a SARS-CoV-2 Monoclonal Antibody, in Healthy Cynomolgus Monkeys

Tolulope A. Aweda,Shih-Hsun Cheng,Stephen C. Lenhard,Armin Sepp,Tinamarie Skedzielewski,Chih-Yang Hsu, Shelly Marshall, Heather Haag,Jonathan Kehler,Prabhas Jagdale,Alessia Peter,Michael A. Schmid,Andrew Gehman,Minh Doan,Andrew P. Mayer,Peter Gorycki,Marie Fanget,Christophe Colas, Brenda Smith, Curtis C. Maier,Hasan Alsaid

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGno. 3 (2023): 667-678

Cited6Views0WOSBibtex

Biodistribution of Sotrovimab, a SARS-CoV-2 monoclonal antibody, using PET imaging in cynomolgus monkey

Tolulope A Aweda,Shih-Hsun Cheng,Stephen Lenhard,Armin Sepp,Tinamarie Skedzielewski,Chih-Yang Hsu, Shelly Marshall, Heather Haag,Jonathan Kehler,Prabhas Jagdale,Alessia Peter,Michael A Schmid,Andrew Gehman,Minh Doan,Andrew Mayer,Peter Gorycki,Marie Fanget,Christophe Colas, Brenda Smith, Cuirtis C Maier,Hasan Alsaid

Research Square (Research Square) (2022)

Cited0Views0Bibtex

Pharmacokinetics, Metabolism and Excretion of Radiolabeled Fostemsavir Administered with or Without Ritonavir in Healthy Male Subjects

Peter Gorycki,Mindy Magee,Peter Ackerman,Xiusheng Miao,Katy Moore

Xenobiotica（2022）

Cited4Views0WOSBibtex

First‐in‐Human Study for a Selective Rearranged During Transfection Tyrosine Kinase Inhibitor, GSK3352589, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers

Beth Ann Reedy,Robin O'Connor-Semmes,Kimberley Hacquoil,Peter Gorycki,Adeline Verticelli,Angela Molga

Clinical Pharmacology in Drug Development（2021）

Cited1Views0WOSBibtex

1315. No Dose Adjustment of Metformin with Fostemsavir Coadministration Based on Mechanistic Static and Physiologically Based Pharmacokinetic Models

Dung N Nguyen,Xiusheng Miao,Mindy Magee,Guoying Tai,Peter D Gorycki,Katy P Moore

Open Forum Infectious Diseases（2020）

Cited0Views0Bibtex

Bioactivation of Herbal Constituents: Mechanisms and Toxicological Relevance

Bo Wen,Peter Gorycki

Drug metabolism reviews（2019）

Cited12Views0WOSBibtex

2500. Fostemsavir Drug–Drug Interaction Profile, an Attachment Inhibitor and Oral Prodrug of Temsavir, for Heavily Treatment Experienced HIV-1-Infected Patients

Katy P Moore, A Savannah Mageau,Mindy Magee,Peter D Gorycki,Peter Ackerman,Cyril Llamoso

Open Forum Infectious Diseases（2019）

Cited10Views0Bibtex

First-in-Human Studies for a Selective RET Tyrosine Kinase Inhibitor, GSK3179106, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers

Melisa Cooper,Robin O'Connor-Semmes,Beth Ann Reedy,Kimberley Hacquoil,Peter Gorycki,Kristen Pannullo,Adeline Verticelli,Sepehr Shakib

Clinical pharmacology in drug development（2018）

Cited2Views0WOSBibtex

Next Generation Ret Kinase Inhibitor: Improved Physicochemical And Pk Properties Enhance Local Gi Tissue Distribution

Michael Demartino,John Russell,Hilary Eidam,Guan Huiping,Peter Gorycki,David Rieman,Melisa Cooper,Reid Groseclose,Stephen Castellino,Ehsan Mohammadi,Beverley Greenwood-Van Meerveld,Allen Oliff,Sanjay Kumar,Mui Cheung

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY（2017）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn